474 related articles for article (PubMed ID: 26979711)
21. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.
Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK
Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078
[TBL] [Abstract][Full Text] [Related]
22. Rigidity controls human desmoplastic matrix anisotropy to enable pancreatic cancer cell spread via extracellular signal-regulated kinase 2.
Malik R; Luong T; Cao X; Han B; Shah N; Franco-Barraza J; Han L; Shenoy VB; Lelkes PI; Cukierman E
Matrix Biol; 2019 Aug; 81():50-69. PubMed ID: 30412725
[TBL] [Abstract][Full Text] [Related]
23. Inactivation of Cancer-Associated-Fibroblasts Disrupts Oncogenic Signaling in Pancreatic Cancer Cells and Promotes Its Regression.
Dauer P; Zhao X; Gupta VK; Sharma N; Kesh K; Gnamlin P; Dudeja V; Vickers SM; Banerjee S; Saluja A
Cancer Res; 2018 Mar; 78(5):1321-1333. PubMed ID: 29259015
[TBL] [Abstract][Full Text] [Related]
24. Tumor Cell-Intrinsic p38 MAPK Signaling Promotes IL1α-Mediated Stromal Inflammation and Therapeutic Resistance in Pancreatic Cancer.
Singh SP; Dosch AR; Mehra S; De Castro Silva I; Bianchi A; Garrido VT; Zhou Z; Adams A; Amirian H; Box EW; Sun X; Ban Y; Datta J; Nagathihalli NS; Merchant NB
Cancer Res; 2024 Apr; 84(8):1320-1332. PubMed ID: 38285896
[TBL] [Abstract][Full Text] [Related]
25. Mesenchymal Plasticity Regulated by Prrx1 Drives Aggressive Pancreatic Cancer Biology.
Feldmann K; Maurer C; Peschke K; Teller S; Schuck K; Steiger K; Engleitner T; Öllinger R; Nomura A; Wirges N; Papargyriou A; Jahan Sarker RS; Ranjan RA; Dantes Z; Weichert W; Rustgi AK; Schmid RM; Rad R; Schneider G; Saur D; Reichert M
Gastroenterology; 2021 Jan; 160(1):346-361.e24. PubMed ID: 33007300
[TBL] [Abstract][Full Text] [Related]
26. CAFs-Associated Genes (CAFGs) in Pancreatic Ductal Adenocarcinoma (PDAC) and Novel Therapeutic Strategy.
Yamashita K; Kumamoto Y
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892190
[TBL] [Abstract][Full Text] [Related]
27. Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs.
Qi R; Bai Y; Li K; Liu N; Xu Y; Dal E; Wang Y; Lin R; Wang H; Liu Z; Li X; Wang X; Shi B
Drug Resist Updat; 2023 May; 68():100960. PubMed ID: 37003125
[TBL] [Abstract][Full Text] [Related]
28. CD146 attenuation in cancer-associated fibroblasts promotes pancreatic cancer progression.
Zheng B; Ohuchida K; Chijiiwa Y; Zhao M; Mizuuchi Y; Cui L; Horioka K; Ohtsuka T; Mizumoto K; Oda Y; Hashizume M; Nakamura M; Tanaka M
Mol Carcinog; 2016 Nov; 55(11):1560-1572. PubMed ID: 26373617
[TBL] [Abstract][Full Text] [Related]
29. Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer.
Ogier C; Colombo PE; Bousquet C; Canterel-Thouennon L; Sicard P; Garambois V; Thomas G; Gaborit N; Jarlier M; Pirot N; Pugnière M; Vie N; Gongora C; Martineau P; Robert B; Pèlegrin A; Chardès T; Larbouret C
Cancer Lett; 2018 Sep; 432():227-236. PubMed ID: 29935372
[TBL] [Abstract][Full Text] [Related]
30. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
[TBL] [Abstract][Full Text] [Related]
31. A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2.
Yang S; He P; Wang J; Schetter A; Tang W; Funamizu N; Yanaga K; Uwagawa T; Satoskar AR; Gaedcke J; Bernhardt M; Ghadimi BM; Gaida MM; Bergmann F; Werner J; Ried T; Hanna N; Alexander HR; Hussain SP
Cancer Res; 2016 Jul; 76(13):3838-50. PubMed ID: 27197190
[TBL] [Abstract][Full Text] [Related]
32. Neoplastic-Stromal Cell Cross-talk Regulates Matrisome Expression in Pancreatic Cancer.
Honselmann KC; Finetti P; Birnbaum DJ; Monsalve CS; Wellner UF; Begg SKS; Nakagawa A; Hank T; Li A; Goldsworthy MA; Sharma H; Bertucci F; Birnbaum D; Tai E; Ligorio M; Ting DT; Schilling O; Biniossek ML; Bronsert P; Ferrone CR; Keck T; Mino-Kenudson M; Lillemoe KD; Warshaw AL; Fernández-Del Castillo C; Liss AS
Mol Cancer Res; 2020 Dec; 18(12):1889-1902. PubMed ID: 32873625
[TBL] [Abstract][Full Text] [Related]
33. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer.
Zhu H; Gao W; Li X; Yu L; Luo D; Liu Y; Yu X
Pancreatology; 2021 Apr; 21(3):589-598. PubMed ID: 33579599
[TBL] [Abstract][Full Text] [Related]
34. The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer.
Higashiguchi M; Murakami H; Akita H; Kobayashi S; Takahama S; Iwagami Y; Yamada D; Tomimaru Y; Noda T; Gotoh K; Doki Y; Yamamoto T; Eguchi H
Oncol Rep; 2023 May; 49(5):. PubMed ID: 36999632
[TBL] [Abstract][Full Text] [Related]
35. Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer.
Niu N; Shen X; Wang Z; Chen Y; Weng Y; Yu F; Tang Y; Lu P; Liu M; Wang L; Sun Y; Yang M; Shen B; Jin J; Lu Z; Jiang K; Shi Y; Xue J
Cancer Cell; 2024 May; 42(5):869-884.e9. PubMed ID: 38579725
[TBL] [Abstract][Full Text] [Related]
36. ECM1 and KRT6A are involved in tumor progression and chemoresistance in the effect of dexamethasone on pancreatic cancer.
Shinomiya Y; Kouchi Y; Harada-Kagitani S; Ishige T; Takano S; Ohtsuka M; Ikeda JI; Kishimoto T
Cancer Sci; 2024 Jun; 115(6):1948-1963. PubMed ID: 38613239
[TBL] [Abstract][Full Text] [Related]
37. Tumor-stroma TGF-β1-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin α
Nan P; Dong X; Bai X; Lu H; Liu F; Sun Y; Zhao X
Cancer Lett; 2022 Mar; 528():59-75. PubMed ID: 34958892
[TBL] [Abstract][Full Text] [Related]
38. Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma.
Pan X; Zhou J; Xiao Q; Fujiwara K; Zhang M; Mo G; Gong W; Zheng L
J Hematol Oncol; 2021 Nov; 14(1):184. PubMed ID: 34727952
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in understanding cancer-associated fibroblasts in pancreatic cancer.
Huang H; Brekken RA
Am J Physiol Cell Physiol; 2020 Aug; 319(2):C233-C243. PubMed ID: 32432930
[TBL] [Abstract][Full Text] [Related]
40. Interleukin 1α sustains the expression of inflammatory factors in human pancreatic cancer microenvironment by targeting cancer-associated fibroblasts.
Tjomsland V; Spångeus A; Välilä J; Sandström P; Borch K; Druid H; Falkmer S; Falkmer U; Messmer D; Larsson M
Neoplasia; 2011 Aug; 13(8):664-75. PubMed ID: 21847358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
